Takeda Pharmaceutical Co Ltd

TD PRIVATE CLIENT WEALTH LLC TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

9,824

Value ($000)

153

Weight

0.0%

2019 Q4 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	153	0.0%	9,824	12/31/2025
2025 Q3	10/27/2025	4	0.0%	253	9/30/2025
2025 Q2	7/15/2025	4	0.0%	253	6/30/2025
2025 Q1	4/29/2025	5	0.0%	317	3/31/2025
2024 Q4	2/11/2025	3	0.0%	238	12/31/2024
2024 Q3	11/18/2024	3	0.0%	238	9/30/2024
2024 Q2	8/14/2024	3	0.0%	238	6/30/2024
2024 Q1	8/16/2024	2	0.0%	115	3/31/2024
2023 Q4	8/16/2024	2	0.0%	115	12/31/2023
2023 Q3	8/16/2024	2	0.0%	115	9/30/2023
2023 Q2	8/16/2024	2	0.0%	115	6/30/2023
2023 Q1	8/16/2024	3	0.0%	202	3/31/2023
2022 Q4	8/16/2024	18	0.0%	1,136	12/31/2022
2022 Q1	8/16/2024	7	0.0%	472	3/31/2022
2021 Q4	8/16/2024	6	0.0%	472	12/31/2021
2021 Q3	8/16/2024	317	0.0%	19,365	9/30/2021
2021 Q2	8/16/2024	440	0.0%	26,130	6/30/2021
2021 Q1	8/16/2024	488	0.0%	26,745	3/31/2021
2020 Q4	8/16/2024	375	0.0%	20,588	12/31/2020
2020 Q3	8/16/2024	384	0.0%	21,546	9/30/2020
2020 Q2	8/16/2024	486	0.0%	27,097	6/30/2020
2020 Q1	8/16/2024	437	0.0%	28,813	3/31/2020
2019 Q4	8/16/2024	364	0.0%	18,430	12/31/2019